Vision Innovation and Venture Forum

Friday, May 3, 2013
Renaissance Seattle Hotel
Seattle, Wash.

The newest ophthalmic innovations with market potential was the focus of this one-day seminar, which will connected scientists, venture capitalists, pharmaceutical representatives and others. Unlike other investor forums, the meeting focused on cutting-edge research, rather than established companies.

The event aimed to help innovators and scientists better understand how products move through the approval and commercialization pipeline, while giving investors insight into treatments and devices that are nearing readiness for commercial development.

Chair — Nicolas G. Bazan, MD, PhD, FARVO



•    The latest advances in science and translational medicine and how  
      they could meet market needs
•    Clinical/regulatory development issues
•    Key concepts of intellectual property
•    Funding
•    How to start and finance companies
•    Pearls from serial entrepreneurs
•    Presentations featuring early-state innovations (therapies and devices)

Vision Innovation and Venture Forum Committee

Nicolas G. Bazan, MD, PhD, FARVO
Robert E. Besthof
Donald C. Hood, PhD, FARVO
Steve Charles, MD, FACS, FICS
Craig E. Crosson, PhD, FARVO
Julia A. Haller, MD, FARVO
Paul P. Lee, MD, JD, FARVO
Sabri Markabi, MD
Samir C. Patel, MD
Joyce Tombran-Tink, PhD, FARVO
Tracy M. Valorie
Gary Walens, RPh

See who spoke at the previous forum.